Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1372140rdf:typepubmed:Citationlld:pubmed
pubmed-article:1372140lifeskim:mentionsumls-concept:C0011315lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0034857lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C1422036lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0178887lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0439599lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C1444662lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C0205132lld:lifeskim
pubmed-article:1372140lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1372140pubmed:issue2lld:pubmed
pubmed-article:1372140pubmed:dateCreated1992-4-15lld:pubmed
pubmed-article:1372140pubmed:abstractTextSixteen overlapping fragments of the dengue-2 virus envelope (E) protein, expressed as trpE-E fusion products in Escherichia coli, were used to map the epitopes defined by a panel of 20 monoclonal antibodies (MAbs) by immunoblotting. Using this technique, the amino acid sequence of six antigenic domains on the E protein was characterized. Nonneutralizing MAbs were found to define either linear-specific, subcomplex-specific (amino acids 22-58), and complex-specific (amino acids 304-332) epitopes or a subcomplex conformational-dependent epitope requiring the presence of two closely linked amino acid sequences from the E protein, 60-97 and 298-397. Neutralizing MAbs, however, defined either group-reactive epitopes present on two overlapping domains (amino acids 60-135; amino acids 60-205) or type-, subcomplex-, complex-, subgroup-, and group-specific determinants (amino acids 298-397). These neutralizing epitopes were all found to be dependent upon disulfide bridges. Our results suggest that the maintenance of a topographical arrangement of discontinuous antigenic domains in the flavivirus E-protein is necessary to induce neutralizing and protective antibodies.lld:pubmed
pubmed-article:1372140pubmed:languageenglld:pubmed
pubmed-article:1372140pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:citationSubsetIMlld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372140pubmed:statusMEDLINElld:pubmed
pubmed-article:1372140pubmed:monthAprlld:pubmed
pubmed-article:1372140pubmed:issn0042-6822lld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:YoungPPlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:MorensD MDMlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:WrightP JPJlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:SchlesingerJ...lld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:GentryM KMKlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:MurrayJ MJMlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:HugnotJ PJPlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:MegretFFlld:pubmed
pubmed-article:1372140pubmed:authorpubmed-author:FalconarAAlld:pubmed
pubmed-article:1372140pubmed:issnTypePrintlld:pubmed
pubmed-article:1372140pubmed:volume187lld:pubmed
pubmed-article:1372140pubmed:ownerNLMlld:pubmed
pubmed-article:1372140pubmed:authorsCompleteNlld:pubmed
pubmed-article:1372140pubmed:pagination480-91lld:pubmed
pubmed-article:1372140pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:meshHeadingpubmed-meshheading:1372140-...lld:pubmed
pubmed-article:1372140pubmed:year1992lld:pubmed
pubmed-article:1372140pubmed:articleTitleUse of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.lld:pubmed
pubmed-article:1372140pubmed:affiliationDepartment of Virology, Institut Pasteur, Paris, France.lld:pubmed
pubmed-article:1372140pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1372140pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372140lld:pubmed